APG Asset Management N.V. Purchases 22,800 Shares of Agilent Technologies, Inc. (A)

APG Asset Management N.V. raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 5.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 481,454 shares of the medical research company’s stock after buying an additional 22,800 shares during the quarter. APG Asset Management N.V. owned about 0.15% of Agilent Technologies worth $30,909,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the business. BlackRock Inc. increased its holdings in Agilent Technologies by 1.2% in the 2nd quarter. BlackRock Inc. now owns 23,392,338 shares of the medical research company’s stock worth $1,387,400,000 after buying an additional 273,119 shares in the last quarter. Vanguard Group Inc. increased its holdings in Agilent Technologies by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 22,093,669 shares of the medical research company’s stock worth $1,310,374,000 after buying an additional 637,698 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Agilent Technologies by 45.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 12,145,610 shares of the medical research company’s stock worth $720,358,000 after buying an additional 3,779,099 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in Agilent Technologies by 1.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,721,557 shares of the medical research company’s stock worth $339,346,000 after buying an additional 84,801 shares in the last quarter. Finally, American Century Companies Inc. increased its holdings in Agilent Technologies by 5.5% in the 2nd quarter. American Century Companies Inc. now owns 4,582,086 shares of the medical research company’s stock worth $271,764,000 after buying an additional 238,522 shares in the last quarter.

A number of equities research analysts have issued reports on A shares. Robert W. Baird restated a “buy” rating and set a $70.00 price target on shares of Agilent Technologies in a research note on Friday, October 20th. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price objective on the stock in a research report on Tuesday, October 10th. Jefferies Group LLC reaffirmed a “buy” rating and set a $66.00 price objective on shares of Agilent Technologies in a research report on Wednesday, August 9th. Cowen and Company reaffirmed a “hold” rating and set a $65.00 price objective on shares of Agilent Technologies in a research report on Thursday, September 28th. Finally, BidaskClub cut Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 12th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $65.65.

In other Agilent Technologies news, CFO Didier Hirsch sold 1,200 shares of the firm’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $66.00, for a total transaction of $79,200.00. Following the completion of the sale, the chief financial officer now owns 164,202 shares of the company’s stock, valued at $10,837,332. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Michael R. Mcmullen sold 16,492 shares of the firm’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $65.33, for a total value of $1,077,422.36. Following the sale, the chief executive officer now directly owns 211,872 shares of the company’s stock, valued at approximately $13,841,597.76. The disclosure for this sale can be found here. In the last quarter, insiders have sold 165,720 shares of company stock worth $10,488,739.

Agilent Technologies, Inc. (NYSE:A) opened at 67.97 on Monday. The stock’s 50 day moving average price is $66.08 and its 200 day moving average price is $60.92. The company has a market cap of $21.87 billion, a P/E ratio of 35.05 and a beta of 1.30. Agilent Technologies, Inc. has a 52-week low of $42.92 and a 52-week high of $68.52.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.07. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The firm had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.09 billion. During the same quarter last year, the business posted $0.49 earnings per share. The firm’s revenue was up 6.7% compared to the same quarter last year. Analysts expect that Agilent Technologies, Inc. will post $2.32 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 25th. Investors of record on Tuesday, October 3rd were given a dividend of $0.132 per share. The ex-dividend date was Monday, October 2nd. This represents a $0.53 dividend on an annualized basis and a yield of 0.78%. Agilent Technologies’s payout ratio is 27.32%.

WARNING: This piece was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://www.com-unik.info/2017/10/30/apg-asset-management-n-v-purchases-22800-shares-of-agilent-technologies-inc-a.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

What are top analysts saying about Agilent Technologies Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Agilent Technologies Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit